Catalyst Pharmaceuticals, Inc.
US ˙ NASDAQCM ˙ US14888U1016 ˙ Medical Devices
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityCPRX / Catalyst Pharmaceuticals, Inc.
InstitutionHDG - ProShares Hedge Replication ETF
Latest Disclosed Ownership119 shares
Latest Disclosed Value $ 2,746
HDG - ProShares Hedge Replication ETF reports 19.59% decrease in ownership of CPRX / Catalyst Pharmaceuticals, Inc.

On April 24, 2026 - HDG - ProShares Hedge Replication ETF filed a NPORT-P form disclosing ownership of 119 shares of Catalyst Pharmaceuticals, Inc. (US:CPRX) valued at $2,747 USD as of February 28, 2026. The entity filed a previous NPORT-P on January 28, 2026 disclosing 148 shares of Catalyst Pharmaceuticals, Inc.. This represents a change in shares of -19.59% during the quarter. The current value of the position is $3,747 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-02-28 NP Catalyst Pharmaceuticals EC US14888U1016 119 -29 -19.59 3 -33.33 0.0112
2026-01-28 2025-11-30 NP Catalyst Pharmaceuticals EC US14888U1016 148 5 3.50 3 50.00 0.0141
2025-10-29 2025-08-31 NP Catalyst Pharmaceuticals EC US14888U1016 143 -6 -4.03 3 -33.33 0.0122
2025-07-28 2025-05-31 NP Catalyst Pharmaceuticals EC US14888U1016 149 17 12.88 4 0.00 0.0152
2025-04-24 2025-02-28 NP Catalyst Pharmaceuticals EC US14888U1016 132 -40 -23.26 3 0.00 0.0122
2025-01-27 2024-11-30 NP Catalyst Pharmaceuticals EC US14888U1016 172 -86 -33.33 4 -40.00 0.0138
2024-10-25 2024-08-31 NP Catalyst Pharmaceuticals EC US14888U1016 258 44 20.56 5 66.67 0.0182
2024-07-29 2024-05-31 NP Catalyst Pharmaceuticals EC US14888U1016 214 12 5.94 3 0.00 0.0124
2024-04-26 2024-02-29 NP Catalyst Pharmaceuticals EC US14888U1016 202 -26 -11.40 3 0.00 0.0115
2024-01-25 2023-11-30 NP Catalyst Pharmaceuticals EC US14888U1016 228 31 15.74 3 50.00 0.0102
2023-10-27 2023-08-31 NP Catalyst Pharmaceuticals EC US14888U1016 197 -21 -9.63 3 0.00 0.0084
2023-07-26 2023-05-31 NP Catalyst Pharmaceuticals EC US14888U1016 218 -50 -18.66 3 -50.00 0.0077
2023-04-24 2023-02-28 NP Catalyst Pharmaceuticals EC US14888U1016 268 -12 -4.29 4 0.00 0.0107
2023-01-25 2022-11-30 NP Catalyst Pharmaceuticals EC US14888U1016 280 21 8.11 5 33.33 0.0109
2022-10-21 2022-08-31 NP Catalyst Pharmaceuticals EC US14888U1016 259 -99 -27.65 4 50.00 0.0084
2022-07-27 2022-05-31 NP Catalyst Pharmaceuticals EC US14888U1016 358 -69 -16.16 3 -33.33 0.0059
2022-04-28 2022-02-28 NP Catalyst Pharmaceuticals EC US14888U1016 427 73 20.62 3 50.00 0.0068
2022-01-27 2021-11-30 NP Catalyst Pharmaceuticals EC US14888U1016 354 24 7.27 2 100.00 0.0056
2021-10-28 2021-08-31 NP Catalyst Pharmaceuticals EC US14888U1016 330 39 13.40 2 0.00 0.0041
2021-07-28 2021-05-31 NP Catalyst Pharmaceuticals EC US14888U1016 291 23 8.58 2 0.00 0.0037
2021-04-27 2021-02-28 NP Catalyst Pharmaceuticals EC US14888U1016 268 -57 -17.54 1 0.00 0.0031
2021-01-27 2020-11-30 NP Catalyst Pharmaceuticals EC US14888U1016 325 5 1.56 1 0.00 0.0040
2020-10-26 2020-08-31 NP Catalyst Pharmaceuticals EC US14888U1016 320 320 1 0.0035
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.